OPKO Health (OPK) News Today $1.51 0.00 (0.00%) (As of 05:19 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period OPKO Health (NASDAQ:OPK) Raised to Hold at StockNews.comStockNews.com upgraded shares of OPKO Health from a "sell" rating to a "hold" rating in a research report on Wednesday.December 18, 2024 | marketbeat.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 125,000 SharesDecember 14, 2024 | insidertrades.comOPKO Health (NASDAQ:OPK) Trading 4% Higher Following Insider Buying ActivityDecember 14, 2024 | americanbankingnews.comOPKO Health, Inc. (NASDAQ:OPK) CEO Buys $198,750.00 in StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 125,000 shares of OPKO Health stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average cost of $1.59 per share, for a total transaction of $198,750.00. Following the completion of the transaction, the chief executive officer now directly owns 212,536,477 shares in the company, valued at $337,932,998.43. This trade represents a 0.06 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.December 13, 2024 | marketbeat.comPhillip Md Et Al Frost Purchases 500,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockDecember 12, 2024 | insidertrades.comCharles Schwab Investment Management Inc. Sells 835,569 Shares of OPKO Health, Inc. (NASDAQ:OPK)Charles Schwab Investment Management Inc. trimmed its holdings in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 16.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,212,355 shares of the biotecDecember 12, 2024 | marketbeat.comIs OPKO Health (OPK) the Best NASDAQ Penny Stock to Buy Right Now?December 11, 2024 | insidermonkey.comNextPlat Gains e-Commerce Access to Over 340 Million Consumers with Launch on JD.Com, China's Largest Online RetailerDecember 10, 2024 | finance.yahoo.comOPKO Health (NASDAQ:OPK) investors are sitting on a loss of 59% if they invested three years agoDecember 8, 2024 | finance.yahoo.comInsider Buying: OPKO Health, Inc. (NASDAQ:OPK) CEO Buys 199,072 Shares of StockNovember 30, 2024 | insidertrades.comOPKO Health, Inc. (NASDAQ:OPK) CEO Purchases $304,580.16 in StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost purchased 199,072 shares of the firm's stock in a transaction that occurred on Friday, November 29th. The stock was bought at an average cost of $1.53 per share, with a total value of $304,580.16. Following the completion of the purchase, the chief executive officer now owns 211,911,477 shares of the company's stock, valued at $324,224,559.81. This represents a 0.09 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.November 29, 2024 | marketbeat.comRubric Capital Management LP Acquires 4,284,336 Shares of OPKO Health, Inc. (NASDAQ:OPK)Rubric Capital Management LP grew its stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 9.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,706,640 shares of the biotechnology company's stockNovember 27, 2024 | marketbeat.comPhillip Md Et Al Frost Acquires 100,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) StockOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost acquired 100,000 shares of the stock in a transaction on Friday, November 22nd. The shares were bought at an average price of $1.59 per share, for a total transaction of $159,000.00. Following the purchase, the chief executive officer now owns 211,712,405 shares in the company, valued at approximately $336,622,723.95. This trade represents a 0.05 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.November 22, 2024 | marketbeat.comOPKO Health to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 20, 2024 | markets.businessinsider.comNextPlat (NASDAQ: NXPL) Expands OPKO Product Promotion at Asia’s Largest Health ExpoNovember 19, 2024 | theglobeandmail.comNextPlat to Showcase OPKO Healthcare Products at the 2024 China International Natural Health & Nutrition ExpoNovember 18, 2024 | prnewswire.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Acquires 100,000 SharesNovember 15, 2024 | insidertrades.comPhillip Frost Buys Handful Of Shares In OPKO HealthNovember 11, 2024 | finance.yahoo.comBarrington Research Estimates OPKO Health FY2028 EarningsOPKO Health, Inc. (NASDAQ:OPK - Free Report) - Equities research analysts at Barrington Research increased their FY2028 earnings estimates for shares of OPKO Health in a report released on Friday, November 8th. Barrington Research analyst M. Petusky now forecasts that the biotechnology company wiNovember 11, 2024 | marketbeat.comOPKO Health Shows Strategic Progress in Q3 2024November 9, 2024 | markets.businessinsider.comOPKO Health Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 9, 2024 | finance.yahoo.comInsider Buying: OPKO Health, Inc. (NASDAQ:OPK) CEO Buys 280,183 Shares of StockNovember 9, 2024 | insidertrades.comOPKO Health: Strategic Maneuvers and Future Profitability Drive Buy RatingNovember 9, 2024 | markets.businessinsider.comOPKO Health, Inc. (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 280,183 SharesOPKO Health, Inc. (NASDAQ:OPK - Get Free Report) CEO Phillip Md Et Al Frost purchased 280,183 shares of the stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $1.50 per share, for a total transaction of $420,274.50. Following the completion of the acquisition, the chief executive officer now directly owns 211,512,405 shares of the company's stock, valued at approximately $317,268,607.50. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this link.November 8, 2024 | marketbeat.comOPKO Health's (OPK) Outperform Rating Reiterated at Barrington ResearchBarrington Research restated an "outperform" rating and set a $2.25 price target on shares of OPKO Health in a report on Friday.November 8, 2024 | marketbeat.comOPKO Health Inc (OPK) Q3 2024 Earnings Call Highlights: A Turnaround in Profitability Amidst ...November 8, 2024 | finance.yahoo.comOPKO Health, Inc. (OPK) Q3 2024 Earnings Conference Call TranscriptNovember 7, 2024 | seekingalpha.comOPKO Health Reports Third Quarter 2024 Business Highlights and Financial ResultsNovember 7, 2024 | finance.yahoo.comOPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Assenagon Asset Management S.A.Assenagon Asset Management S.A. boosted its stake in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 142.5% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,490,992 shares of the biotechnology company's stock after acquiring an additional 876,272 sharNovember 1, 2024 | marketbeat.comOPKO Health (OPK) Set to Announce Earnings on ThursdayOPKO Health (NASDAQ:OPK) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=641656)October 31, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Shares Up 4.7% - What's Next?OPKO Health (NASDAQ:OPK) Stock Price Up 4.7% - Should You Buy?October 29, 2024 | marketbeat.comWith 50% ownership, OPKO Health, Inc. (NASDAQ:OPK) insiders have a lot riding on the company's futureOctober 18, 2024 | finance.yahoo.comRenaissance Technologies LLC Cuts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK)Renaissance Technologies LLC lowered its holdings in OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 79.3% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 284,743 shares of the biotechnology company's stock after selling 1,0October 12, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Stock Price Up 4.1% - Time to Buy?OPKO Health (NASDAQ:OPK) Shares Up 4.1% - Here's What HappenedOctober 9, 2024 | marketbeat.comSquarepoint Ops LLC Acquires Shares of 473,216 OPKO Health, Inc. (NASDAQ:OPK)Squarepoint Ops LLC bought a new position in OPKO Health, Inc. (NASDAQ:OPK - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 473,216 shares of the biotechnology company's stock, valued at apprOctober 9, 2024 | marketbeat.comModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza ProgramOctober 7, 2024 | globenewswire.comOPKO Health (NASDAQ:OPK) Stock, Insider Trading ActivityOctober 5, 2024 | benzinga.comOPKO Health (NASDAQ:OPK) Trading Up 5%OPKO Health (NASDAQ:OPK) Trading Up 5%October 2, 2024 | marketbeat.comGlobal Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6% by 2030 | DelveInsightSeptember 26, 2024 | finance.yahoo.comBuy Rating Justified by Opko Health’s Promising OXM Candidate and Strategic Asset SaleSeptember 26, 2024 | markets.businessinsider.comEntera Bio, OPKO Health Announce Positive Results For Oxyntomodulin Animal Models Against ObesitySeptember 25, 2024 | markets.businessinsider.comOPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical DevelopmentSeptember 23, 2024 | markets.businessinsider.comOPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Rubric Capital Management LPRubric Capital Management LP boosted its position in shares of OPKO Health, Inc. (NASDAQ:OPK - Free Report) by 800.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 44,422,304 shares of the biotechnology company's stock aSeptember 21, 2024 | marketbeat.comOpko Health’s Strategic Moves and Financial Prospects Bolster Buy RatingSeptember 21, 2024 | markets.businessinsider.comOPKO Health (NASDAQ:OPK) Earns "Outperform" Rating from Barrington ResearchBarrington Research reissued an "outperform" rating and set a $2.25 price objective on shares of OPKO Health in a research note on Friday.September 20, 2024 | marketbeat.comGeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA AnalyticsSeptember 20, 2024 | msn.comOpko Health (OPK) Receives a Buy from Piper SandlerSeptember 18, 2024 | markets.businessinsider.comOpko Health’s Strategic Moves and Pipeline Progress Prompt Buy RatingSeptember 18, 2024 | markets.businessinsider.comOPKO Health (NASDAQ:OPK) Stock Price Down 2.4%OPKO Health (NASDAQ:OPK) Stock Price Down 2.4%September 18, 2024 | marketbeat.comOPKO Health (NASDAQ:OPK) Shares Gap Down to $1.64OPKO Health (NASDAQ:OPK) Shares Gap Down to $1.64September 17, 2024 | marketbeat.com Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address Six Stocks That Could Soar on Trump’s First Day Back (Ad)The recent election results have clarified a path forward, creating opportunities that weren't as clear just months ago. Louis has identified six specific AI stocks that are poised to benefit from this. Click here to learn which AI companies Louis believes will dominate the market... OPK Media Mentions By Week OPK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPK News Sentiment▼-0.080.56▲Average Medical News Sentiment OPK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPK Articles This Week▼13▲OPK Articles Average Week Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FOLD News Today LGND News Today GERN News Today MNKD News Today DVAX News Today CLDX News Today BCRX News Today NVAX News Today MYGN News Today INVA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPK) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OPKO Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPK Stock Alerts